Hoover Financial Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$42K Sell
457
-49
-10% -$4.36K 0.01% 302
2021
Q1
$44K Sell
506
-40
-7% -$3.59K 0.01% 276
2020
Q4
$52K Buy
+546
New +$47.7K 0.01% 238
2020
Q3
Sell
-457
Closed -$40K 378
2020
Q2
$40K Buy
+457
New +$39.4K 0.02% 206

Other funds holding NVS

Hoover Financial Advisors's NVS Position: Q2 2021 in Review

Hoover Financial Advisors reduced its Novartis (NVS) stake by 9.7% in Q2 2021, selling an estimated $4.36K and leaving 457 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #302.

Hoover Financial Advisors first reported a position in NVS in Q2 2020 and has held it in 4 quarters since. The position peaked at $52K in Q4 2020. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

  • Hoover Financial Advisors held 457 shares of Novartis worth $42K as of Q2 2021.
  • Hoover Financial Advisors sold 49 Novartis shares in Q2 2021, an estimated $4.36K.
  • Novartis made up 0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #302 holding.
  • Hoover Financial Advisors first reported a position in Novartis in Q2 2020 and has held it in 4 quarters since.
  • Hoover Financial Advisors's Novartis position peaked at $52K in Q4 2020.
  • 1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.